Thats because neither its therapeutic potential nor its safety has been tested on people
Keywords: nose to brain delivery system, lipid based nanoparticle, in situ gel, bypassing BBB Introduction Global healthcare data indicate a significant increase in the prevalence of central nervous system (CNS) diseases, which contribute approximately 68% to the global economy
In the Phase II obesity clinical trial MOMENTUM-1, a 2.4 mg dose of pemvidutide resulted in an average weight loss of 15.6% after 48 weeks, with the placebo-corrected figure being 13.4%
The C Rating is simply a measure of how fast the battery can be discharged safely and without harming the battery
Acetylated EGCG derivatives have shown improved cellular uptake and metabolic stability and are designed to release active EGCG through enzymatic or chemical hydrolysis at target sites, providing sustained therapeutic effects
Effects of time-release caffeine containing supplement on metabolic rate, glycerol concentration and performance